China NMPA Drug Inspection - Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. - Metformin Hydrochloride Extended-Release Tablets
China NMPA drug inspection for Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. published July 24, 2017. Drug: Metformin Hydrochloride Extended-Release Tablets. The Shaanxi Provincial Food and Drug Administration (Shaanxi FDA) issued a Drug Quality Announcement on July 24, 2017, p
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. published July 24, 2017. Drug: Metformin Hydrochloride Extended-Release Tablets. The Shaanxi Provincial Food and Drug Administration (Shaanxi FDA) issued a Drug Quality Announcement on July 24, 2017, p
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox